GBM cells disrupt the integrity of the blood-brain barrier (BBB) during tumor initiation and release multiple cytokines such as the chemokine stromal cell-derived factor 1-α (CXCL12) to recruit monocytes or macrophages to the tumor site (44, 45). The gene discussed is CXCL12; the disease is neoplasm.